SMTL ID : 5swo.1

Crystal Structure of PI3Kalpha in complex with fragments 4 and 19

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

hetero-1-1-mer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 1 residues within 4Å: Chain A: E.877 Ligand excluded by PLIP

1 x 70T: 2-methyl-5-nitro-1H-indole(Non-covalent)

70T.2: 4 residues within 4Å: Chain A: K.299, S.657, F.694, C.866 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.694 pi-Stacking: A:F.694 pi-Cation interactions: A:R.846

1 x 2ZV: 4-methyl-3-nitropyridin-2-amine(Non-covalent)

2ZV.3: 4 residues within 4Å: Chain A: N.633 Chain B: N.23, N.56, N.57 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.56, B:N.57

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miller, M.S. et al., Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design. Bioorg. Med. Chem. (2017)

Release Date

2017-02-15

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A
Phosphatidylinositol 3-kinase regulatory subunit alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence